Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ishares Msci Thailand Etf (THD) vs GeneDx Holdings Corp (WGS) Price & Performance

Ishares Msci Thailand EtfTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Ishares Msci Thailand Etf vs GeneDx Holdings Corp — how do they compare? Ishares Msci Thailand Etf trades at $72.91, while GeneDx Holdings Corp trades at $81.74 (market cap $2.32B). The key difference: Ishares Msci Thailand Etf is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.

THDWGS
Sector
Broad Market / FactorTechnology
52-Week High
$75.05$167.51
52-Week Low
$56.41$34.51
Market Cap
$2.32B
Enterprise Value
$2.35B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ishares Msci Thailand Etf

THD trades at $73.63, up 1.03% for the day, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The stock has shown strong performance, driven by exposure to AI hardware plays like Delta Electronics, contributing to its 38% total returns over the past year, as noted by Seeking Alpha on July 9, 2026. A dividend of $1.71 is scheduled for June 2026, adding income potential.

Outlook remains positive due to AI-driven growth, but risks include vulnerability to semiconductor sector volatility and foreign capital outflows from Asian equities. Investors should weigh the bullish technicals against macroeconomic uncertainties in the region for balanced exposure.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $77.08, up 10.76% today, showing strong momentum despite negative profitability metrics. The stock exhibits bullish technical signals with support at $72 and resistance at $80. Recent Q2 2026 earnings beat expectations with $0.01 EPS versus -$0.19 estimate, while revenue reached $114.4 million. However, the company faces significant challenges with a -23.4% net income margin and ongoing securities class action litigation.

Investment outlook remains cautiously optimistic given strong analyst support (90.9% buy rating) and $79.25 consensus price target. Key opportunities include growing genomic testing volumes and improved operational efficiency, while risks center on profitability challenges, legal liabilities, and high valuation multiples that may not justify current fundamentals.

Returns comparison

Trailing returns across standard periods

About Ishares Msci Thailand Etf

THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.

Read more on THD

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS